A French approach to cost-effectiveness analysis? Gérard de Pouvourville Editorial 03 November 2010 Pages: 521 - 523
The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration Kathleen Melissa Ke Original Paper 21 November 2009 Pages: 525 - 531
Adolescents alcohol-use and economic conditions: a multilevel analysis of data from a period with big economic changes Mikael SvenssonCurt Hagquist Original Paper 10 December 2009 Pages: 533 - 541
The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands Marcus Richard Keogh-BrownRichard D. SmithPhilippe Beutels Original Paper 09 December 2009 Pages: 543 - 554
The effect of health care expenditure on sickness absence David Granlund Original Paper 06 January 2010 Pages: 555 - 568
The sustainability of public health expenditures: evidence from the Canadian federation Livio Di Matteo Original Paper 12 January 2010 Pages: 569 - 584
The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden Michael WillisMarianne SvenssonUlf Persson Original Paper 19 January 2010 Pages: 585 - 594
On the welfare theoretic foundation of CEA: comment Friedrich Breyer Original Paper 15 October 2010 Pages: 595 - 596
Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply Bengt Liljas Original Paper 19 October 2010 Pages: 597 - 598
Erratum to: Hospital’s activity-based financing system and manager–physician interaction David CrainichHervé LeleuAna Mauleon Erratum 31 August 2010 Pages: 599 - 599